These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5972623)

  • 1. Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.
    Sharman DF
    Br J Pharmacol Chemother; 1966 Nov; 28(2):153-63. PubMed ID: 5972623
    [No Abstract]   [Full Text] [Related]  

  • 2. The monoamine metabolism in viral encephalitides of the mouse. II. Turnover of monoamines in mice infected with herpes simplex virus.
    Lycke E; Roos BE
    Brain Res; 1972 Sep; 44(2):603-13. PubMed ID: 4342444
    [No Abstract]   [Full Text] [Related]  

  • 3. Acid metabolites of monoamines in avian brain; effects of probenecid and reserpine.
    Ahtee L; Sharman DF; Vogt M
    Br J Pharmacol; 1970 Jan; 38(1):72-85. PubMed ID: 5413292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of drugs on regional brain concentrations of dopamine and dihydroxyphenylacetic acid.
    Umezu K; Moore KE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):49-56. PubMed ID: 32385
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of mouse brain tryptophan hydroxylase activity.
    Cho TM; Loh HH
    Pharmacology; 1973; 10(4):215-9. PubMed ID: 4762216
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 8. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of drugs acting in relation to sympathetic functions on the analgesic action of morphine.
    Contreras E; Tamayo L
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):312-20. PubMed ID: 4380922
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine mediation of the morphine-induced activation of mice.
    Carroll BJ; Sharp PT
    Br J Pharmacol; 1972 Sep; 46(1):124-39. PubMed ID: 4263794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of morphine tolerance and dependence from brain serotonin synthesis rate in mice.
    Schechter PJ; Lovenberg W; Sjoerdsma A
    Biochem Pharmacol; 1972 Mar; 21(5):751-3. PubMed ID: 5063173
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amine metabolism in the human brain: further evaluation of the probenecid test.
    Korf J; Van Praag HM
    Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate.
    Spano PF; Tagliamonte A; Tagliamonte P; Gessa GL
    J Neurochem; 1971 Oct; 18(10):1831-6. PubMed ID: 5118337
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of enzymes that synthesize neurotransmitter monoamines.
    Fuller RW; Steinberg M
    Adv Enzyme Regul; 1976; 14():347-390. PubMed ID: 9790
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines.
    Nakanishi M; Setoguchi M
    Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of various drugs on 3,4-dihydroxyphenylalanine (DL-DOPA)-induced excitation (agressive behavior) in mice.
    Yen HC; Katz MH; Krop S
    Toxicol Appl Pharmacol; 1970 Nov; 17(3):597-604. PubMed ID: 5531444
    [No Abstract]   [Full Text] [Related]  

  • 18. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Turnover of biogenic amines after acute and chronic morphine treatment in rats.
    Theiss P; Papeschi R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R98. PubMed ID: 4276659
    [No Abstract]   [Full Text] [Related]  

  • 20. 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine?
    Roffler-Tarlov S; Sharman DF; Tegerdine P
    Br J Pharmacol; 1971 Jul; 42(3):343-51. PubMed ID: 5560896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.